How to treat Lung cancer?

['Yoká lokasa oyo']

Ndenge nini kosalisa kanser ya mimpululu?

Ndenge ya kosalisa kanser ya mimpululu etalelaka makambo mingi, na ndakisa ndenge kanser yango ezali, lolenge ya kanser ya mimpululu, mpe sante ya moto.

Lolenge mosusu ya kosalisa oyo bato mingi basalelaka ezali:

1. Lipaso: Mbala mingi, yango nde lolenge ya liboso ya kosalisa kanser ya mimpululu oyo ezali naino na ebandeli.

Monganga akolongola kanser yango mpe mwa ndambo ya baselile oyo ezali zingazinga na yango.

2. Kosalisa na kongɛngisa: Kosalisa na kongɛngisa makasi mpenza ebomaka baselile ya kanser mpe ekitaka.

Ekoki kosalelama yango moko to na nzela ya bankisi mosusu.

3. Chemothérapie: Mpo na kosalisa maladi yango, basalelaka bankisi mpo na koboma baselile ya kanser.

Ekoki kopesama na nzela ya ntonga to na monɔkɔ, mpe mbala mingi basalelaka yango esika moko na bankisi mosusu.

4. Kosalisa na mikrobe oyo ezali na kanser: Kosalisa na mikrobe yango ezali kosalisa na kobundisa mikrobe oyo ezali na ba gènes to baproteini oyo esalaka ete baselile ya kanser ekola mpe ekufa te.

Mbala mingi basalelaka yango mpo na kanser ya mimpululu oyo ezali na stade ya makasi to oyo epanzani.

5. Immunothérapie: Kosalisa nzoto na kobundisa mikrobe esalisaka nzoto na kobundisa mikrobe oyo ebundisaka kanser.

Mbala mingi basalelaka yango mpo na kanser ya mimpululu oyo ezali na stade ya makasi to oyo epanzani.

6. Photodynamic therapy: Mwango yango ezali kosalela nkisi oyo ebimisaka kongɛnga mpo na koboma baselile ya kanser.

Mbala mingi basalelaka yango mpo na kanser ya mimpululu oyo ezali naino na ebandeli.

7. Proton therapy: Ezali lolenge ya radiothérapie oyo esalelaka ba protons na esika ya ba rayons X mpo na kopesa radiation na tumeur.

Mbala mingi basalelaka yango mpo na kanser ya mimpululu oyo ezali naino na ebandeli.

8. Komeka bankisi: Bato ya maladi bakoki kondima komeka bankisi ya sika to bankisi oyo esangisi bankisi ndenge na ndenge.

Ezali na ntina kosolola na minganga mpo na koyeba nkisi nini ebongi, mpo nkisi oyo ebongi mpenza ekotalela makambo ya moto na moto.

['Makambo oyo ezali na buku yango']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Chen JH, Wu J, Xu Q: The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct Target Ther. , 4 (): 61.

Furuse K: [Photodynamic therapy of centrally located early-stage lung cancer]. Gan To Kagaku Ryoho. 1996, 23 (1): 27-30.

Gálffy G: [From rare mutations to classical ones, inhibition of signaling pathways in non-small cell lung cancer]. Magy Onkol. 2020, 64 (3): 196-204.

Magalhães M, Alvarez-Lorenzo C, Concheiro A, Figueiras A, Santos AC, Veiga F: RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers. Expert Opin Drug Deliv. 2018, 15 (10): 965-982.

Kataoka M, Fujiwara T, Tanaka N: [Gene therapy for lung cancer]. Nihon Geka Gakkai Zasshi. 2002, 103 (2): 244-9.

Jin C, Yang B: A Case of Delayed Diagnostic Pulmonary Tuberculosis during Targeted Therapy in an EGFR Mutant Non-Small Cell Lung Cancer Patient. Case Rep Oncol. , 14 (1): 659-663.

Wang Y, Liu Q, Chen H, You J, Peng B, Cao F, Zhang X, Chen Q, Uzan G, Xu L, Zhang D: Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance. Anticancer Drugs. 2018, 29 (8): 748-755.

['Koboya: makambo ya monganga']

['Site oyo ezali kaka mpo na koteya mpe koyebisa bato makambo ya monganga, kasi ezali te mpo na kopesa toli to toli ya monganga.']

['Makambo oyo ezali na site yango esengeli te kosalelama mpo na koyeba maladi to kosalisa yango, mpe baoyo balingi kozwa toli ya monganga basengeli kotuna yango epai ya monganga oyo ayebi mosala yango malamu.']

['Tosengi na yo oyeba ete réseau neuronal oyo epesaka biyano na mituna, ezalaka mpenza malamu te soki ezali na makambo ya mituya. Na ndakisa, motango ya bato oyo bazali na maladi moko boye.']

['Sololá ntango nyonso na monganga to na moto mosusu oyo ayebi kosalisa maladi na yo. Koboya toli ya monganga te to kozela te mpo otángi likambo moko na site oyo. Soki okanisi ete ozali na maladi oyo esengeli kosalisa yo nokinoki, bengá 911 to kende na lopitalo ya pene. Site oyo to ndenge oyo ozali kosalela yango ezali na boyokani te na monganga ná moto oyo azali kosalisa yo.']

["Kozanga ndingisa: droit d'auteur"]

['Mobeko ya Copyright ya Milenere ya 1998, 17 U.S.C. § 512 (DMCA) epesi nzela na bakomi ya mikanda oyo bakanisi ete biloko oyo ezali na Internet ezali kobebisa lotomo na bango na kolanda mibeko ya copyright ya Etats-Unis. ']

['Soki ondimi na motema malamu ete makambo to biloko oyo ezali na site Internet to na ba service na biso ezali kobuka mibeko na yo, yo (to moto oyo azali na mokumba ya kobatela yo) okoki kotindela biso mokanda mpo na kosɛnga ete tólongola makambo to biloko yango to tópekisa yo kokɔta na yango. ']

['Basengeli kotinda bansango na mokanda na nzela ya email (tala na "Kotindelana" mpo na adresse ya email). ']

['Mibeko ya DMCA esengi ete mokanda na yo ya kofunda mbeba ya copyright ezala na makambo oyo elandi: (1) kolimbola mosala oyo ezali na droit ya copyright oyo bazali kofunda ete ebebisami; (2) kolimbola makambo oyo bazali kofunda ete ebebisi mpe makambo oyo ekoki mpo na kosalisa biso na koyeba esika makambo yango ezali; (3) makambo ya kosolola na yo, ata mpe adrɛsi na yo, nimero ya telefone mpe adrɛsi ya e-mail; (4) mokanda oyo okomi ete ondimi na motema malamu ete makambo oyo ozali kofunda ete ebebisami epesami nzela te na nkolo ya droit ya copyright, to na agent na ye, to na mibeko nyonso; ']

['(5) mokanda oyo okomi, oyo okotya sinyatili na yango mpo na komonisa ete makambo oyo okomaki ezali solo mpe ete ozali na lotomo ya kolandela lotomo ya babimisi oyo bazali koloba ete ebebisami; ']

['mpe (6) sinyatili ya moto oyo azali na lotomo ya kosala yango to ya moto oyo azali na lotomo ya kosala na nkombo na ye. ']

['Soki otye makambo nyonso te oyo ezali awa na likolo, yango ekoki kosala ete likambo na yo eumela.']

['Ndenge ya kosolola']

['Tosengi otindela biso email na motuna to likanisi nyonso.']

How to treat lung cancer?

The treatment for lung cancer depends on several factors, including the stage of the cancer, the type of lung cancer, and the patient's overall health.

Some common treatment options include:

1. Surgery: This is often the preferred treatment for early-stage lung cancer.

The surgeon removes the tumor and a small portion of healthy tissue around it.

2. Radiation therapy: High-energy radiation is used to kill cancer cells and shrink tumors.

It can be used alone or in combination with other treatments.

3. Chemotherapy: This treatment uses drugs to kill cancer cells.

It can be given intravenously or or orally, and is often used in combination with other treatments.

4. Targeted therapy: This treatment targets specific genes or proteins that contribute to the growth and survival of cancer cells.

It is often used for advanced or metastatic lung cancer.

5. Immunotherapy: This treatment helps the immune system recognize and attack cancer cells.

It is often used for advanced or metastatic lung cancer.

6. Photodynamic therapy: This treatment uses a light-activated drug to kill cancer cells.

It is often used for early-stage lung cancer.

7. Proton therapy: This is a type of radiation therapy that uses protons instead of x-rays to deliver radiation to the tumor.

It is often used for early-stage lung cancer.

8. Clinical trials: Patients may be eligible to participate in clinical trials testing new treatments or combinations of treatments.

It is important to discuss the best treatment options with a healthcare team, as the most effective treatment plan will depend on the individual's specific situation.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.